Citius Receives FDA Response on Pre-Investigational New Drug Application for its Induced Mesenchymal Stem Cells to Treat Acute Respiratory Distress Syndrome in Patients with COVID-19
– FDA provides very specific guidelines to study iPSC-derived MSCs – Company intends to submit an IND application for its iMSC therapy for patients with ARDS associated with COVID-19 CRANFORD, N.J., June 26, 2020 /PRNewswire/ […]